Efficacy of Topical Hydroxypinacolone Retinoate‐Peptide Product Versus Fractional CO 2 Laser in Facial Aging
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.16621 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Lucas Kruger und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinique, New York, New York, USA. Hauptthemen laut MEDLINE: Skin Aging, Lasers, Gas, Cosmetic Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Many people are interested in addressing visible signs of aging with non‐invasive cosmetic treatments. Development of effective topical products will provide options to delay or support cosmetic procedures.
Aims
This study assessed and compared the efficacy and tolerance of a topical product used over the course of 16 weeks to a single ablative laser treatment on women with moderate global photodamage on the face.
Methods
Subjects in Cell 1 (Laser Cell) were treated over the entire face with a fractional CO 2 laser system. Subjects in Cell 2 (Topical Serum Cell) were treated with a topical serum containing hydroxypinacolone retinoate and peptides over the entire face, twice per day for 16 weeks. The study was composed of 71 women, with 29 in the Laser Cell (mean age 56.2) and 42 in the Topical Serum Cell (mean age 55.0), between 40 and 65 years old. Expert grading was used to determine efficacy parameters.
Results
Participants in the Topical Serum Cell achieved more significant improvement ( p < 0.05) in Marionette lines, fine lines (global face), wrinkles (global face), wrinkles (crow's feet), nasolabial folds, texture, smoothness (tactile), global hyperpigmentation, lift, and photodamage compared to participants in the Laser Cell. Participants in the Topical Serum Cell achieved parity in the look of fine lines (crow's feet), forehead lines, glabella, firmness/bounce (tactile), skin tone evenness, radiance.
Conclusions
While no statistically significant differences in tolerability were observed, treatment with the topical cosmetic product achieved parity or statistically better improvement in parameters compared to laser treatment at 16 weeks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinique, New York, New York, USA.
- Research and Development, The Estée Lauder Companies, Melville, New York, USA.
- Orentreich Medical Group, New York, New York, USA.
Zitieren
APA
Kruger, L., Bambino, K., Schmalenberg, K., Santhanam, U., Orentreich, D., Orentreich, C., Logerfo, J., & Saliou, C. (2025). Efficacy of Topical Hydroxypinacolone Retinoate‐Peptide Product Versus Fractional CO 2 Laser in Facial Aging. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16621
Vancouver
Kruger L, Bambino K, Schmalenberg K, Santhanam U, Orentreich D, Orentreich C, et al. Efficacy of Topical Hydroxypinacolone Retinoate‐Peptide Product Versus Fractional CO 2 Laser in Facial Aging. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.16621
BibTeX
@article{Kruger2025,
author = {Kruger, Lucas and Bambino, Kathryn and Schmalenberg, Kristine and Santhanam, Uma and Orentreich, David and Orentreich, Catherine and Logerfo, Jodi and Saliou, Claude},
title = {Efficacy of Topical Hydroxypinacolone Retinoate‐Peptide Product Versus Fractional CO 2 Laser in Facial Aging},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.16621}
}
EUVIMED